Published in Cancer Vaccine Week, November 10th, 2003
According to a study from Sweden, "Around half of all human tumors carry mutant p53.
"This allows escape from p53-induced cell cycle arrest and apoptosis. Many tumors express mutant p53 proteins at elevated levels," wrote V.J.N. Bykov and colleagues, Karolinska Institute, Department Oncology & Pathology.
"Restoration of wild-type p53 function should trigger massive apoptosis in tumor cells and thus eradicate tumors. Various types of small molecules have been identified that can restore native conformation and wild-type function to mutant p53," the researchers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.